Nov. 20, 2023, 6:31 p.m. | Anne-Sophie Gill


MONTREAL, November 21, 2023 – Simmunome Inc., a Montreal-based techbio company leveraging generative artificial intelligence (AI) to increase the predictability of clinical drug development announces today its partnership with Mila – Quebec AI Institute, the world’s largest academic deep learning research center.  Simmunome integrates multi-omic data to generate in silico disease models that accurately capture...

Read More

The post Simmunome and Mila Announce Partnership to Advance AI in Drug Development appeared first on Mila.

academic advance artificial artificial intelligence center clinical data deep learning development drug development generate generative generative artificial intelligence institute intelligence partnership research techbio world

Machine Learning Postdoctoral Fellow

@ Lawrence Berkeley National Lab | Berkeley, Ca

Team Lead Data Integrity

@ Maximus | Remote, United States

Machine Learning Research Scientist

@ Bosch Group | Pittsburgh, PA, United States

Data Engineer

@ Autodesk | APAC - India - Bengaluru - Sunriver

Data Engineer II

@ Mintel | Belfast

Data Engineer

@ Vector Limited | Auckland, New Zealand